Haemonetics, the global leader in blood management solutions, is expanding its existing operations in Union County, South Carolina. The company is investing nearly $20 million in the expansion, which is expected to create 40 new jobs over the next five years.
Established in 1971, Haemonetics recently celebrated 20 years at its current Union County site, located at 155 Medical Sciences Drive in Union, South Carolina. In this latest investment, the company will be expanding the existing facility by 3,000 square-feet, as well as making significant upgrades to plant equipment and infrastructure.
Products manufactured at the Union County site are required for plasmapheresis, during which the raw material in life saving plasma therapies is collected. Therapies treat a variety of disease states including immune deficiencies, hemophilia, and other blood disorders.
“The South Carolina community has been an integral partner in our manufacturing operations for the last 20 years, and our decision to further invest in the Union facility reflects upon the diverse pool of talent, partners and resources that South Carolina has to offer. I look forward to continuing our strategy of continuous improvement and manufacturing excellence in Union, helping to further support our global product lines,” Haemonetics Corporation CEO Ron Gelbman added.
As an incentive, Coordinating Council for Economic Development has approved a $400,000 Rural Infrastructure Fund grant to Union County to assist with the cost of real property improvements. The Council has also approved job development credits related to the project.
“Haemonetics has been doing business in South Carolina for 20 years, and it’s exciting to see this great company make the decision to expand here. This nearly $20 million investment, and the 40 new jobs it will bring to Union County, is a testament to Haemonetics’ commitment to South Carolina, and we look forward to watching its continued success here for many years to come,” said Governor Nikki Haley.